Global Haemophilia Market - Analysis By Type (Haemophilia A, Haemophilia B), By Treatment (On-demand, Prophylaxis), By Region, By Country (2019 Edition): Opportunities and Forecasts (2013-2023) -- By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, Germany, UK, Japan, China, India, Brazil)

Table of Contents 

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Haemophilia Outlook

5. Global Haemophilia Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Haemophilia Market: Segment Analysis
6.1 Global Haemophilia Market Size, By Type: Breakdown (%)
6.1.1 Global Haemophilia Market Size, By Type, 2017 (%)
6.1.2 Global  Haemophilia Market Size, By Type, 2023 (%)
6.2 Global Haemophilia A Market, By Value (2013-2023)
6.3 Global Haemophilia B Market, By Value (2013-2023)
6.4 Global  Haemophilia Market Size, By Treatment: Breakdown (%)
6.4.1 Global Haemophilia Market Size, By Treatment, 2017 (%)
6.4.2 Global Haemophilia Market Size, By Treatment, 2023 (%)
6.5 Global On- demand Haemophilia Market, By Value (2013-2023)
6.6 Global Prophylaxis Market, By Value (2013-2023)

7. Global Haemophilia Market: Regional Analysis
7.1 Global Haemophilia Market Size, By Region : Breakdown (%)
7.1.1 Global Haemophilia Market Size, By Region, 2017 (%)
7.1.2 Global Haemophilia Market Size, By Region, 2023 (%)

7.2 North America Haemophilia Market: Growth and Forecast
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.2.3 By Type, By Value (2013-2017)
7.2.4 By Type, By Value (2018-2023)
7.2.5 By Treatment, By Value (2013-2017)
7.2.6 By Treatment, By Value (2018-2023)

7.3 North America Haemophilia Market: Country Analysis (U.S and Canada)
7.3.1 U.S Haemophilia Market, By Value (2013-2023)
7.3.2 U.S Haemophilia Market, By Type, By Value (2013-2017)
7.3.3 U.S Haemophilia Market, By Type, By Value (2018-2023)
7.3.4 U.S Haemophilia Market, By Treatment, By Value (2013-2017)
7.3.5 U.S Haemophilia Market, By Treatment, By Value (2018-2023)
7.3.6 Canada Haemophilia Market, By Value (2013-2023)
7.3.7 Canada Haemophilia Market, By Type, By Value (2013-2017)
7.3.8 Canada Haemophilia Market, By Type, By Value (2018-2023)
7.3.9 Canada Haemophilia Market, By Treatment, By Value (2013-2017)
7.3.10 Canada Haemophilia Market, By Treatment, By Value (2018-2023)

7.4 Europe Haemophilia Market: Growth and Forecast
7.4.1 By Value (2013-2017)
7.4.2 By Value (2018-2023)
7.4.3 By Type, By Value (2013-2017)
7.4.4 By Type, By Value (2018-2023)
7.4.5 By Treatment, By Value (2013-2017)
7.4.6 By Treatment, By Value (2018-2023)

7.5 Europe Haemophilia Market: Country Analysis (U.K and Germany)
7.5.1 U.K Haemophilia Market, By Value (2013-2023)
7.5.2 U.K Haemophilia Market, By Type, By Value (2013-2017)
7.5.3 U.K Haemophilia Market, By Type, By Value (2018-2023)
7.5.4 U.K Haemophilia Market, By Treatment, By Value (2013-2017)
7.5.5 U.K Haemophilia Market, By Treatment, By Value (2018-2023)
7.5.6 Germany Haemophilia Market, By Value (2013-2023)
7.5.7 Germany Haemophilia Market, By Type, By Value (2013-2017)
7.5.8 Germany Haemophilia Market, By Type, By Value (2018-2023)
7.5.9 Germany Haemophilia Market, By Treatment, By Value (2013-2017)
7.5.10 Germany Haemophilia Market, By Treatment, By Value (2018-2023)

7.6 APAC Haemophilia Market: Growth and Forecast
7.6.1 By Value (2013-2017)
7.6.2 By Value (2018-2023)
7.6.3 By Type, By Value (2013-2017)
7.6.4 By Type, By Value (2018-2023)
7.6.5 By Treatment, By Value (2013-2017)
7.6.6 By Treatment, By Value (2018-2023)

7.7 APAC Haemophilia Market: Country Analysis (Japan, India and China)
7.7.1 Japan Haemophilia Market, By Value (2013-2023)
7.7.2 Japan Haemophilia Market, By Type, By Value (2013-2017)
7.7.3 Japan Haemophilia Market, By Type, By Value (2018-2023)
7.7.4 Japan Haemophilia Market, By Treatment, By Value (2013-2017)
7.7.5 Japan Haemophilia Market, By Treatment, By Value (2018-2023)
7.7.6 India Haemophilia Market, By Value (2013-2023)
7.7.7 India Haemophilia Market, By Type, By Value (2013-2017)
7.7.8 India Haemophilia Market, By Type, By Value (2018-2023)
7.7.9 India Haemophilia Market, By Treatment, By Value (2013-2017)
7.7.10 India Haemophilia Market, By Treatment, By Value (2018-2023)
7.7.11 China Haemophilia Market, By Value (2013-2023)
7.7.12 China Haemophilia Market, By Type, By Value (2013-2017)
7.7.13 China Haemophilia Market, By Type, By Value (2018-2023)
7.7.14 China Haemophilia Market, By Treatment, By Value (2013-2017)
7.7.15 China Haemophilia Market, By Treatment, By Value (2018-2023)

7.8 ROW Haemophilia Market: Growth and Forecast
7.8.1 By Value (2013-2017)
7.8.2 By Value (2018-2023)
7.8.3 By Type, By Value (2013-2017)
7.8.4 By Type, By Value (2018-2023)
7.8.5 By Treatment, By Value (2013-2017)
7.8.6 By Treatment, By Value (2018-2023)

7.9 ROW Haemophilia Market: Country Analysis (Brazil)
7.9.1 Brazil Haemophilia Market, By Value (2013-2023)
7.9.2 Brazil Haemophilia Market, By Type, By Value (2013-2017)
7.9.3 Brazil Haemophilia Market, By Type, By Value (2018-2023)
7.9.4 Brazil Haemophilia Market, By Treatment, By Value (2013-2017)
7.9.5 Brazil Haemophilia Market, By Treatment, By Value (2018-2023)

8. Global Haemophilia Market Dynamics
8.1 Global Haemophilia Market Drivers
8.2 Global Haemophilia Market Restraints

9. Global Haemophilia Market Trends

10. Porter Five Force Analysis

11. SWOT Analysis

12. Supply Chain Analysis

13. Competitive Landscape

14. Policy and Regulatory Landscape

15. Company Profiles
15.1 Bayer
15.2 Novo Nordisk
15.3 Pfizer
15.4 Roche
15.5 Aptevo Therapeutics
15.6 Catalyst BioSciences
15.7 Dimension Therapeutics
15.8 Shire
15.9  CSL Behring
15.10 Alnylam Pharmaceuticals